NCT01973608 MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma Status TERMINATED Phase PHASE2
NCT01972568 Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT01971515 First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01963611 Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1) Status TERMINATED Phase PHASE2
NCT01936363 Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01782976 Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM) Status WITHDRAWN Phase PHASE2
NCT01693068 Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma Status COMPLETED Phase PHASE2
NCT01689337 A Multicenter Trial of Sprifermin (AS902330 [Recombinant Human Fibroblast Growth Factor-18]) or Placebo After Microfracture Surgery for Cartilage Injury of the Knee Status TERMINATED Phase PHASE2
NCT01390818 Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01378377 Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus Status TERMINATED Phase PHASE1
NCT01369628 Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil Status TERMINATED Phase PHASE1